Close

AstraZeneca's (AZN) MOVENTIG Receives Marketing Approval from EC

December 9, 2014 7:46 AM EST Send to a Friend
AstraZeneca (NYSE: AZN) announced that MOVENTIG (naloxegol) has been granted Marketing Authorisation by the European Commission (EC) for the treatment ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login